Shaker, Ehab Hanafy
Soliman, Ahmed Mohamed
Bedewy, Ahmed Abd Elmohsen
Elrawas, Mai Mohamed
Funding for this research was provided by:
National Cancer Institute (NCI) in Egypt
Article History
Received: 25 June 2024
Accepted: 1 November 2024
First Online: 8 January 2025
Declarations
:
: After approval of the ethical committee at the National Cancer Institute (NCI) - Cairo University (AP2307-501-058) and registration at clinicaltrials.gov (NCT 06005558), all patients’ guardians gave written informed consent. Data was collected anonymously and all participants’ guardians were informed about the target and benefits of the study.
: Not applicable.
: Every human participant should provide their consent.
: The authors declare no competing interests.